Mediwound's nexobrid® to be highlighted in 36 scientific presentations at the 21st european burns association congress

Mediwound's nexobrid ® to be highlighted in 36 scientific presentations at the 21st european burns association congress yavne, israel, september 2, 2025 -- mediwound ltd. (nasdaq: mdwd), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced its participation at the 21st european burns association (eba) congress, taking place september 3-6, 2025, in berlin, germany.
MDWD Ratings Summary
MDWD Quant Ranking